April 23, 2024

BeLAB21/22 BRIDGE

BeLAB21/22 BRIDGE
Go back

Mediated and supported by bioRN, Evotec established in 2021 the beLAB2122 BRIDGE. With 20M Euro Fund for preclinical development of academic drug discovery projects, beLAB2122 is a new public-private partnership between the leading academic institutions of the Rhine-Neckar region, Evotec and Bristol Myers Squibb to identify, fund and execute novel disease modifying therapeutic projects with the goal to develop these to new spinout companies.

tester

Our latest News

discover more
All Experimentica sites are now CIR-accredited

All Experimentica sites are now CIR-accredited

Experimentica’s sites have gained CIR accreditation for 2026-2028, enabling eligible French companies to benefit from CIR-covered preclinical ophthalmic research services. Experimentica’s Kuopio and Vilnius sites are now both CIR-accredited for 2026–2028. Our Kuopio site has held the accreditation since 2020, and with the addition of our Vilnius site, French biotech and pharmaceutical companies can access […]

read more
Helmholtz Doctoral Award for Mariam Amghar

Helmholtz Doctoral Award for Mariam Amghar

In her doctoral thesis at the German Cancer Research Center (DKFZ), Mariam Amghar investigated why some prostate cancer patients respond to radioactive drugs while others do not. Her findings may help tailor treatment more effectively to individual patients in the future. Mariam Amghar has been awarded the Helmholtz Doctoral Prize in the “Health” category. At […]

read more
Mirco Friedrich Receives the Peter and Traudl Engelhorn Foundation Award

Mirco Friedrich Receives the Peter and Traudl Engelhorn Foundation Award

Mirco Julian Friedrich, a physician and cancer researcher at the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Research Institute, and Heidelberg University Hospital (UKHD), is being honored for his outstanding research on the aging immune system and the immune response to blood cancer. Mirco Friedrich leads a junior research group at the DKFZ […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp